Folic Acid Supplementation During Early Pregnancy and the Risk of Gestational Hypertension and Preeclampsia
- 1 April 2013
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hypertension
- Vol. 61 (4) , 873-879
Abstract
Emerging evidence has suggested that folic acid–containing multivitamins may markedly reduce the risk of gestational hypertension or preeclampsia. We examined whether maternal supplementation with folic acid alone during early pregnancy can prevent the occurrence of gestational hypertension and preeclampsia. The data are from a large population-based cohort study established to evaluate the effectiveness of the campaign to prevent neural tube defects with folic acid supplementation in China. We selected participants who were registered in 2 southern provinces, had exact information on folic acid use, and were not affected by chronic hypertension or diabetes mellitus before 20 weeks gestation. A logistic regression model was used to adjust for the effects of the main potential confounders, including age, body mass index, education, occupation, parity, and multiple births. The study size had 99.9% power (α=0.05) to detect a decrease of 10% over the unexposed rate of 9.4% for gestational hypertension. Among the 193 554 women (47.9% took folic acid, 52.1% did not), the overall incidence of gestational hypertension and preeclampsia was 9.5% and 2.5%, respectively. The incidence of gestational hypertension and preeclampsia was 9.7% and 2.5% for women who took folic acid, and 9.4% and 2.4% for women who did not use it. The adjusted risk ratio associated with folic acid use was 1.08 (95% confidence interval, 1.04–1.11) for gestational hypertension and 1.11 (95% confidence interval, 1.04–1.18) for preeclampsia. Our findings suggest that daily consumption of 400 μg folic acid alone during early pregnancy cannot prevent the occurrence of gestational hypertension and preeclampsia.Keywords
This publication has 31 references indexed in Scilit:
- Study of Serum Homocysteine, Folic Acid and Vitamin B12 in Patients with PreeclampsiaIndian Journal of Clinical Biochemistry, 2011
- Hypertension in pregnancy as a risk factor for cardiovascular disease later in lifeJournal Of Hypertension, 2010
- Hypertensive Disorders in Pregnancy and Subsequently Measured Cardiovascular Risk FactorsObstetrics & Gynecology, 2009
- Effect of Homocysteine Concentration in Early Pregnancy on Gestational Hypertensive Disorders and Other Pregnancy OutcomesClinical Chemistry, 2008
- Homocysteine, folic acid and B12 serum levels in pregnancy complicated with preeclampsiaArchives of Gynecology and Obstetrics, 2006
- Summary of the NHLBI Working Group on Research on Hypertension During PregnancyHypertension, 2003
- Elevated plasma homocysteine in early pregnancy: A risk factor for the development of severe preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2001
- Plasma Folate, Vitamin B12, and Homocyst(e)ine Concentrations in Preeclamptic and Normotensive Peruvian WomenAmerican Journal of Epidemiology, 2001
- Elevated Second-Trimester Serum Homocyst(e)ine Levels and Subsequent Risk of PreeclampsiaGynecologic and Obstetric Investigation, 1999
- High prevalence of hemostatic abnormalities in women with a history of severe preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1999